Targeting Microbiota 2018 already confirmed speakers


Antibiotics and microbiota: Recent scientific advances and perspectives
Maria Vehreschild, University Hospital of Cologne, Germany

MAIT cells (Mucosal-Associated Invariant T cells) in liver disease and antibacterial response
Antonio Riva, Institute of Hepatology London, Foundation for Liver Research, United Kingdom

Exploring the role of gut dysbiosis in neuroinflammation and hypertension
David Durgan, Baylor College of Medicine, USA

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Sara Federici, Weizmann Institute of Science, Israel

Role of gut phages in child stunting
Mohammadali Khan Mirzaei, McGill University, Canada

Crosstalk between Gut Microbiota, Innate Immune Cells and Endocrine Cells in the Pancreas Regulates Autoimmune Diabetes
Julien Diana, Institut National de la Santé et de la Recherche Médicale (INSERM), France

Psycho neuro immunology and gut microbes
Paul Forsythe, McMaster University, Canada

Role of microbes in stem cells transplantation related complication
Ernst Holler, University Hospital Regensburg, Germany

The effect of gut bacterial metabolites on cardiovascular risk
Marcin Ufnal, Medical University of Warsaw, Poland

Targeted gut Microbiota and short chain fatty acid profile among term and preterm infants
Jan Mazela, 
Poznan University of Medical Sciences, Poland

This list will be regularly updated.